Concepedia

Micha Loebermann

ML

23

Publications

746

Citations

16

H-Index

2004

Active since

Affiliations

University of Rostock(Current)

Medical University of Graz

Medical University of Vienna

Novartis (Germany)

Micha Loebermann is an author at University of Rostock specializing in medicine, immunology, and pathogenesis.

ORCID

Top concepts

Publications per year

2004–2022

23

Publications

23

Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial

Emil C. Reisinger, Roland Tschismarov, Eckhard Beubler et al. · The Lancet · 2018 · 176 citations

, , +6

Immunogenicity and predictors of response to a single dose trivalent seasonal influenza vaccine in multiple sclerosis patients receiving disease‐modifying therapies

Christoph Metze, Alexander Winkelmann, Micha Loebermann et al. · CNS Neuroscience & Therapeutics · 2018 · 80 citations · Full text

24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis

Martina Sombetzki, Claudia Fuchs, Peter Fickert et al. · Journal of Hepatology · 2014 · 67 citations · Full text

Schistosoma mansoni: Schistosomicidal effect of mefloquine and primaquine in vitro

Martha Holtfreter, Micha Loebermann, Sebastian Klammt et al. · Experimental Parasitology · 2010 · 40 citations

, , +7

Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial

Jacqueline Palace, Dean M. Wingerchuk, Kazuo Fujihara et al. · Multiple Sclerosis and Related Disorders · 2020 · 37 citations · Full text

Rows per page

1–5 of 23